Cargando…

Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy

For non-small cell lung cancer (NSCLC), radiotherapy (RT) and platinum-based chemotherapy (CHT) are among the main treatment options. On the other hand, radioresistance and cytotoxic drug resistance are common causes of failure. The epidermal growth factor receptor (EGFR) plays an important role in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butkiewicz, Dorota, Krześniak, Małgorzata, Gdowicz-Kłosok, Agnieszka, Giglok, Monika, Marszałek-Zeńczak, Małgorzata, Suwiński, Rafał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197839/ https://www.ncbi.nlm.nih.gov/pubmed/34070597 http://dx.doi.org/10.3390/ijms22115605

Ejemplares similares

DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients
por: Butkiewicz, Dorota, et al.
Publicado: (2023)

Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma
por: Butkiewicz, Dorota, et al.
Publicado: (2022)

Association of Genetic Variants in ANGPT/TEK and VEGF/VEGFR with Progression and Survival in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy or Radiochemotherapy
por: Butkiewicz, Dorota, et al.
Publicado: (2020)

Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer
por: Suwinski, Rafał, et al.
Publicado: (2019)

Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity
por: Krześniak, Małgorzata, et al.
Publicado: (2020)

Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet
por: Kozłowska, Emilia, et al.
Publicado: (2020)

Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity
por: Łasut-Szyszka, Barbara, et al.
Publicado: (2021)

Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients
por: Zajkowicz, A, et al.
Publicado: (2015)

Quantitative analysis of plasma DNA in anal cancer patients
por: Małusecka, Ewa, et al.
Publicado: (2022)

A functional analysis of G23A polymorphism and the alternative splicing in the expression of the XPA gene
por: Butkiewicz, Dorota, et al.
Publicado: (2010)

Radiotherapy-related changes in serum proteome patterns of head and neck cancer patients; the effect of low and medium doses of radiation delivered to large volumes of normal tissue
por: Widłak, Piotr, et al.
Publicado: (2013)

Significance of HPV16 Viral Load Testing in Anal Cancer
por: Małusecka, Ewa, et al.
Publicado: (2020)

Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol
por: Zajkowicz, Artur, et al.
Publicado: (2013)

Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer
por: Mazurek, Agnieszka M., et al.
Publicado: (2023)

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
por: Smolska-Ciszewska, Beata, et al.
Publicado: (2015)

Differences in the intraspecies copy number variation of Arabidopsis thaliana conserved and nonconserved miRNA genes
por: Samelak-Czajka, Anna, et al.
Publicado: (2023)

The impact of circulating regulatory T cells number and their subpopulations on risk of lymph node metastasis
por: Wydmanski, Jerzy, et al.
Publicado: (2015)

MLPA-Based Analysis of Copy Number Variation in Plant Populations
por: Samelak-Czajka, Anna, et al.
Publicado: (2017)

Analysis of Arabidopsis non-reference accessions reveals high diversity of metabolic gene clusters and discovers new candidate cluster members
por: Marszalek-Zenczak, Malgorzata, et al.
Publicado: (2023)

Evaluation of Efficacy and Tolerance of Radical Radiotherapy and Radiochemotherapy in Treatment of Locally Advanced, Unresectable Rectal Cancer
por: Kraszkiewicz, M., et al.
Publicado: (2022)

Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer
por: Suwinski, Rafal
Publicado: (2021)

Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study
por: Abramowicz, Agata, et al.
Publicado: (2015)

Application of Pilates-based exercises in the treatment of chronic non-specific low back pain: state of the art
por: Eliks, Małgorzata, et al.
Publicado: (2019)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
por: Gupta, Arunima, et al.
Publicado: (2014)

Unresectable Extraskeletal Myxoid Chondrosarcoma of the Neck: Early Tumor Response to Chemoradiotherapy
por: Zaki, Mark, et al.
Publicado: (2015)

Salvage surgery after definitive chemoradiotherapy through VATS for an initial unresectable locally advanced lung cancer: an alternative consolidative modality to radiotherapy?
por: Yu, Hsuan-Hsuan, et al.
Publicado: (2021)

Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Administration Rates
por: Eichkorn, Tanja, et al.
Publicado: (2020)

Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma
por: Ding, Yuxun, et al.
Publicado: (2021)

Safety and efficacy analysis of chemoradiotherapy/radiotherapy combined with nimotuzumab for treating unresectable oesophageal squamous cell carcinoma in elderly patients: a retrospective analysis
por: Zhang, Yu, et al.
Publicado: (2022)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma
por: Ranganathan, Sarangarajan, et al.
Publicado: (2016)

Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

Prophylactic cranial irradiation in SCLC
por: Suwinski, Rafal
Publicado: (2021)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
por: Kim, Young-Il, et al.
Publicado: (2013)

Unresectable esophageal cancer treated with multiple chemotherapies in combination with chemoradiotherapy: A case report
por: Yura, Masahiro, et al.
Publicado: (2021)

The Impact of Weight Loss during Chemoradiotherapy for Unresectable Esophageal Cancer: Real-World Results
por: Huang, Tzu-Ting, et al.
Publicado: (2022)

EGFR-targeting peptide-coupled platinum(IV) complexes
por: Mayr, Josef, et al.
Publicado: (2017)

Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients
por: Guo, Zhen, et al.
Publicado: (2017)

Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy
por: Jiang, Wei, et al.
Publicado: (2022)

Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer
por: Qiu, Bo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_us6bp84fhpf08a7c9ae5stm10c